about
siRNA Versus miRNA as Therapeutics for Gene SilencingMicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal CancersGetting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-ReviewInhibition of atherosclerosis-promoting microRNAs via targeted polyelectrolyte complex micelles.MicroRNA delivery for regenerative medicine.Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivoStem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer.Engineering Periodic shRNA for Enhanced Silencing Efficacy.Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotidesOptimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles.Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells.Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7.Polyethyleneimine-capped silver nanoclusters for microRNA oligonucleotide delivery and bacterial inhibition.Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's Disease.Diblock Copolymer Hydrophobicity Facilitates Efficient Gene Silencing and Cytocompatible Nanoparticle-Mediated siRNA Delivery to Musculoskeletal Cell Types.RNAi-Mediated Knockdown of Protein Expression.Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease.Evaluating side effects of nanoparticle-mediated siRNA delivery to mesenchymal stem cells using next generation sequencing and enrichment analysis.Light-triggered RNA release and induction of hMSC osteogenesis via photodegradable, dual-crosslinked hydrogels.Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles
P2860
Q26786876-AD43FF89-F28B-4DC7-B56E-E8A8167F9954Q28076754-7C414E05-172E-4DEF-92D2-895C59F36769Q28079707-0020C6A8-275E-4A17-8D7A-A57F0B19C055Q35067820-E3098AA9-E55B-42D8-9624-0CE5135AA44FQ35863950-5415EB0A-A76D-434D-93FF-9096BEA16323Q36360773-3ECDA6A0-5E91-4006-AB4A-391A0CEF7F88Q36471345-3F40191C-632F-44C7-8040-68F7919DF1FBQ37043521-B01F2067-4092-4133-84C3-674FA06C6738Q39038930-40A6B74B-D21E-4B8E-9334-009B2DAD4339Q39041906-925FC821-1EF9-419F-98FA-BC0D13F57845Q39662387-46844AED-5ECE-4DF8-BB99-E8C1A0127EC2Q40736574-333DEEC9-E223-4151-A549-4A3FABA336FCQ41482927-53B88FFB-2E92-4B6A-9889-D559633582DAQ42109363-EE111BE0-831B-4F82-83D8-27D044E1E06EQ47104222-2C2852C3-3E16-4B56-B8DE-DF1982054878Q47130088-1D6667C7-C2D5-45A2-883C-70F1ECCCFD8EQ47148640-4A378BE8-5C29-4026-8C99-D21349B5884AQ47684243-C188B2EB-3116-4238-9000-8D0CA76019F8Q48171300-BCED2C70-8A32-4CBE-B7F2-FA597F0AD900Q51008485-6F7A1EB0-8AD4-4D8E-82B7-19F311CDBE4EQ51309757-C979427A-27A9-4CD7-A0AD-21033B69C22AQ57170401-B93193B0-3A2B-43BB-BD63-9D592444C1FF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Polyethylenimines for siRNA and miRNA delivery in vivo.
@en
type
label
Polyethylenimines for siRNA and miRNA delivery in vivo.
@en
prefLabel
Polyethylenimines for siRNA and miRNA delivery in vivo.
@en
P2860
P356
P1476
Polyethylenimines for siRNA and miRNA delivery in vivo.
@en
P2093
Sabrina Höbel
P2860
P304
P356
10.1002/WNAN.1228
P50
P577
2013-05-29T00:00:00Z